Skip to content


  • Poster presentation
  • Open Access

Novel Second Generation Anti-HIV shRNA Expressing vif and Decoy TAR Arrest the Virus-breakthrough Phenomenon Associated With siRNA-escape Variants

  • 1, 4,
  • 1, 2,
  • 1,
  • 1,
  • 3,
  • 3 and
  • 1, 2Email author
Retrovirology20052 (Suppl 1) :P36

  • Published:


  • Human Immunodeficiency Virus
  • Synergistic Effect
  • Gene Therapy
  • Cleavage Site
  • Response Region

We describe a novel chimera RNA expressing vif short-hairpin RNA (shRNA) and decoy trans-activation response region (TAR) RNA from a human U6 Pol II promoter, which enhanced the inhibition of human immunodeficiency virus (HIV) vif small-interfering RNA (siRNA) and arrested virus breakthrough by siRNA-generated escape variants in long-term culture assays. Our strategy was based on a second-generation anti-HIV-1 shRNA vector system, in which HIV-1 vif shRNA was fused to a decoy TAR RNA by a linker UU cleavage site to generate vif shRNA-decoy TAR RNA. Upon expression, the RNA molecule was cleaved and separated into vif siRNA and decoy TAR RNA. The synergistic effect of these molecules enhanced the inhibition of HIV-1 replication in a long-term culture assay and prevented virus breakthrough associated with siRNA-mediated escape variants. Combining shRNA with decoy TAR RNA as second-generation anti-HIV shRNA may provide practical basis for applying siRNA-based gene therapy to the treatment of HIV/AIDS.


Authors’ Affiliations

Dept. Life Environ. Sci, Center, Chiba Inst. Tech., Narashino, Chiba, Japan
High Tech. Res. Center, Chiba Inst. Tech., Narashino, Chiba, Japan
NIHDiseases, AIDS Res. Center, Shinjuku-ku, Tokyo, Japan
Dept. Virol, Noguchi Memo. Inst. Univ., Ghana, Accra-Ghana


© The Author(s) 2005